ISPECTAMAB DEBOTANSINE
UNII WY39ZX6NZU

Substance Identification & Data

This profile provides standardized clinical and technical data for Ispectamab Debotansine, uniquely identified by the FDA Unique Ingredient Identifier (UNII) WY39ZX6NZU.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2413386-21-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
WY39ZX6NZU
CAS Registry Number
2413386-21-5
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ISPECTAMAB DEBOTANSINE
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
12079
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ispectamab Debotansine. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ISPECTAMAB DEBOTANSINE

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN B-CELL MATURATION ANTIGEN) (HUMAN MONOCLONAL SP8893 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL SP8893 .KAPPA.-CHAIN, DIMER, 186,410-BIS(4-((8-(3-AMINO-1-OXOPROPYL)-8,9-DIHYDRO-1H(OR 3H)-DIBENZO(B,F)-1,2,3-TRIAZOLO(4,5-D)AZOCIN-1(OR 3)-YL)METHYL)-L-PHENYLALANINE), AMIDE WITH N2'-(20-CARBOXY-6-METHYL-1,5-DIOXO-9,12,15,18-TETRAOXA-6-AZAEICOS-1-YL)-N2'-DEACETYLMAYTANSINE
ISPECTAMAB DEBOTANSINE [INN]
ISPECTAMAB DEBOTANSINE [WHO-DD]